Sophia Genetics Sa (SOPH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SOPH Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Sophia Genetics Sa manages its resources, obligations, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents70.29
Cash & Short-term Investments70.00
Trade & Other Current Receivables (IFRS combined total)15.00
Notes Receivable, Current6.35
Other Current Assets20.61
Total Current Assets99.08
Equipment/Property/Plant Net5.67
Intangible Assets35.89
Tax Assets, Noncurrent2.26
Other Assets, Noncurrent21.97
Total Assets163.03
Liabilities
Longterm Borrowings47.73
Other Liabilities, Current2.80
Total Current Liabilities50.53
Long-term debt0.88
Total Long-term Debt0.88
Accrued Income Taxes, Noncurrent0.42
Other liabilities, Noncurrent64.48
Total Liabilities115.89
Stockholders' Equity
Other Equity47.15
Common Stockholder's Equity47.15
Total Stockholder's Equity47.15
Liabilities & Stockholder's Equity163.03
4 historic quarters locked

Sign in to unlock the full Sophia Genetics Sa balance sheet history.

About Sophia Genetics Sa Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001840706-26-000006

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.